Company intelligence / Profile preview

Dermasilkrx

Boca Raton, Florida, United States

Ownership: Private
Development stage: Other

Overview

DermasilkRx is a pharmaceutical company focused on providing prescription-strength dermatological treatments through a streamlined telehealth and delivery model. The company offers a range of topical medications targeting common skin conditions such as acne, rosacea, and hyperpigmentation. By integrating clinical consultation with pharmacy fulfillment, DermasilkRx aims to increase patient access to specialized skincare regimens. Their product portfolio typically includes customized formulations of established active ingredients like tretinoin, hydroquinone, and azelaic acid.

Therapeutic areas: Dermatology
Modalities: Small molecule
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Dermasilkrx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dermasilkrx.

Explore the full profile